CD20

Immunohistochemical location of CD20 positive cells in the early human embryos

人早期胚中CD20阳性细胞的免疫组织化学定位

Objective To investigate the distribution and significance of CD20 positive cells in the early human embryo .

目的探索CD20阳性细胞在人早期胚中的分布及意义。

The number of CD20 ~ + B cell decreased more than 80 % .

CD20+B细胞减少80%以上。

Expression of B cell - specific activator protein and CD20 in lymphoproliferative disorders

B细胞特异性激活蛋白与CD20在淋巴组织增生性疾病中的表达

Preparation and function assay of monoclonal antibodies against human CD20 by recombinant CD20 antigen

利用基因重组抗原研制人CD20单克隆抗体及其功能的研究

Distribution of B lymphocyte subgroup CD20 and its clinical significance in patients with myasthenia gravis

重症肌无力患者胸腺内B淋巴细胞亚群CD20的分布及临床意义

Construction and expression of chimeric anti-human CD20 monoclonal antibody

抗CD20嵌合抗体的构建与表达

Preparation and characterization of a humanized anti-human CD20 monoclonal antibody

抗CD20人源化抗体的制备及生物学活性鉴定

ObjectiveTo obtain human recombinant CD20 molecule and study the expression of human CD20 in vaccinia virus .

目的获得重组人CD20分子并研究编码人CD20的基因在痘苗病毒中的表达。

Prognostic significance of CD20 expression in adults with precursor B-lineage acute lymphoblastic leukemia

成人前B急性淋巴母细胞性白血病CD20表达与预后的关系

Expressions of CD3 , cd20 , cd68 in early syphilis lesions

早期梅毒皮损组织CD3、CD20和CD68的表达

Construction , Expression and Characterization of Anti-CD20 Chimeric Monoclonal Antibody and Discovery of Interaction Protein of CD20

抗CD20嵌合抗体的构建、表达和功能研究以及CD20相互作用蛋白的初步研究

In this paper , T cell and CD20 in 28 cases of Patients with infantile viral myocarditis were detected .

本文对28例小儿病毒性心肌炎患者进行了T细胞检测，发现患儿外周血T细胞亚群有明显改变。

Rituximab : A monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris

利妥昔单抗：一种用于治疗寻常型天疱疮的抗CD20单克隆抗体

The absence of CD20 messenger RNA in recurrent cutaneous B - cell lymphoma following rituximab therapy

经利妥昔单抗治疗后复发的皮肤B细胞淋巴瘤出现CD20信使RNA缺失

Objective To study the biological response of B-cell lymphoma cells positive for CD20 expression to 131I-labeled rituximab .

目的研究131I标记的rituximab对CD20高表达的B细胞淋巴瘤细胞的生物学效应，为放射免疫导向治疗提供实验依据。

Objective To assess the distribution and clinical significance of B-lymphocyte subgroup CD20 in patients with myasthenia gravis .

目的了解胸腺内B淋巴细胞与重症肌无力发生的关系。

Objective : To construct and express anti CD3 / anti CD20 Diabody and identify its biological activity .

目的：构建和表达抗CD3/抗CD20微型双功能抗体，并测定该微型双功能抗体的生物学活性。

A chimeric antibody against CD20 on B cell was constructed and expressed in CHO cell and its characters was studied .

表达了基因重组抗CD20嵌合抗体并对其生物学活性进行了初步鉴定。

In addition , immunochemistry of CD34 , CD20 , and leukocyte common antigen was detected .

同时进行白细胞共同抗原、CD34、CD20的免疫组化观察。

Roles of CD45RO , CD20 and local IgE in the pathogenesis of vocal fold polyps

CD45ROCD20及总IgE在声带息肉组织中表达的研究

Conclusion : Rituximab can bind to B cells which express CD20 antigen and induce B cell apoptosis by antigen-antibody reaction .

结论：抗CD20抗体能靶向性地与表达CD20抗原的B细胞结合，通过抗体抗原反应，诱导B细胞加速凋亡。

These indicate that CD19 may be a better antibody targeting molecule than CD20 for patients with B-lineage acute leukemia .

这提示CD19抗原分子可能成为治疗B系ALL的最佳靶点。

CD20 + B cells showed a similar profile to that of granulocytes , positive cells being ( 96.3 ± 0 6 ) % .

B细胞的表达均为完全阳性，表达率高达（963±0.6）%，与中性粒细胞类似。

Rituximab specifically recognizes and attaches to a protein called CD20 that is found on the surface of some lymphocytes .

美罗华特异的识别和附着于在一些淋巴细胞表面可以找到蛋白CD20。

Additionally , CD20 involves in signal transduction through store-operated calcium entry ( SOCE ) .

CD20还通过钙池调控钙离子进入（SOCE）参与了细胞信号传导。

CD20 ~ + B cells may be related to the continuous immune response and excessively hyperplastic changes in the cutaneous lesions of LP .

CD20+B细胞可能与疾病的持续存在及局部过度增殖性改变有关。

CD19 and CD20 were detected in 88 34 % and 37 48 % of the immortalized B cell membrane respectively .

细胞系冻存复苏后，活性良好：分别有8834%和3748%的永生化B细胞膜上表达CD19和CD20；

Results Many germinal centers were observed under lymph node capsule , in which FDC networks were found with the same distribution of CD20 + B cells ;

结果正常淋巴结被膜下分布着多个生发中心，其内可见FDC网络，与CD20+B细胞分布一致；

Rituximab is a chimeric monoclonal antibody against human CD20 , Rituximab treatment results in rapid depletion of CD20 positive B cells in peripheral blood .

Rituximab是抗人CD20嵌合单克隆抗体，可以快速去除外周血CD20阳性B淋巴细胞。